Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The International Prevention Research Institute (iPRI) is an independent research organization dedicated to improving public health through the prevention of chronic diseases, with a primary focus on oncology. Based in Lyon, France, iPRI conducts large-scale epidemiological studies, biostatistical analysis, and provides strategic consultancy to governments, non-governmental organizations, and the private sector. The institute's work encompasses identifying risk factors, evaluating screening programs, and developing evidence-based strategies for disease control on a global scale. iPRI is widely recognized for its contributions to major public health initiatives and its role in producing comprehensive reports on the global state of oncology. The organization operates as a bridge between academic research and policy implementation, aiming to reduce the global burden of preventable diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Prevention Research Institute.